Reactive oxygen in fruit flies acts as a cell signalling mechanism for immune responseSeptember 24, 2009For years, health conscious people have been taking antioxidants to reduce the levels of reactive oxygen in their blood and prevent the DNA damage done by free radicals, which are the result of oxidative stress. But could excessive use of antioxidants deplete our immune systems? Research at UCLA's Jonsson Comprehensive Cancer Center has raised that question. It has been known for decades that reactive oxygen species (ROS) - ions or very small molecules that include free radicals - damage cells. But much to their surprise, Jonsson Cancer Center researchers found that in Drosophila, the common fruit fly, moderately elevated levels of ROS are a good thing. These small molecules act as an internal communicator, signaling certain blood precursor cells, or blood stem cells, to differentiate into immune-bolstering cells in reaction to a threat. After the progenitor cells differentiate, the ROS levels return to normal, ensuring the safety and survival of the mature blood cells, said Utpal Banerjee, a Jonsson Cancer Center researcher and senior author of the study. The study is published in the Sept. 24, 2009 issue of the peer-reviewed journal Nature. The new finding was launched when Banerjee and his team set out to discover why fruit flies had naturally occurring, slightly elevated levels of ROS in their blood cell precursors, which is atypical of most other precursor cells. "Reducing levels of reactive oxygen is usually the goal, and what we found was surprising," said Banerjee, professor and chairman of the molecular, cell, and developmental biology department at UCLA. "Most stem cells don't want to be damaged, so they have very low ROS levels. We wanted to know why this was different in the cells that we were investigating." Banerjee discovered that when ROS was taken away in the blood stem cells, they failed to differentiate into the immune-bolstering cells, called macrophages. On the other hand, when levels of ROS were further increased by genetic means, the blood stem cells "differentiated like gang busters," Banerjee said, making a large number of macrophages. But how did this happen? The ROS, Banerjee said, acted as a signaling mechanism that kept the blood stem cells in a certain state - when levels rose, it was a message to the cell to differentiate. The implications from the finding are several fold, Banerjee said. The blood stem cells are stress sensing cells, their function is to sense conditions that increase oxidative stress and react with an immune response. Keeping their ROS levels slightly elevated puts the cells on alert, sensitized and ready to respond to any threat quickly. That sparked a question: If fruit fly blood stem cells and mammalian blood stem cells operate in the same way, is it a good thing for people to be taking antioxidants? Are antioxidants dulling the immune system and its ability to react to threats? "On the one hand, it's good to have antioxidants to reduce the amount of reactive oxygen in our body that causes DNA damage," Banerjee said. "But if we find that those blood stem cells aren't primed to respond because the ROS levels are reduced, that would not be a good thing. Our findings raise the possibility that wanton overdose of antioxidant products may in fact inhibit formation of cells participating in innate immune response." It is known that certain types of mammalian blood stem cells, called common myeloid progenitors, do have elevated levels of ROS, but it isn't known whether those levels operate as messengers for differentiation. Studies of mammalian systems are needed to determine why ROS levels are elevated and what, if any, function that serves in the cell. It is interesting, however, that these types of blood progenitors in mammals also give rise to macrophages, Banerjee said. "What we found is that the fruit fly keeps its own ROS levels in the blood stem cells slightly high for its own benefit," Banerjee said. "We do not have any direct evidence that this is true in humans, but our results suggest that further studies are needed to investigate a possible signaling role for ROS in the differentiation of precursor cells in mammalian myeloid cell development and oxidative stress response." University of California - Los Angeles |
|||||||||||||||||||||
| Related Stem Cells Current Events and Stem Cells News Articles First reconstitution of an epidermis from human embryonic stem cells Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM* Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells. Bone Implant Offers Hope for Skull Deformities A synthetic bone matrix offers hope for babies born with craniosynostosis, a condition that causes the plates in the skull to fuse too soon. Your Own Stem Cells Can Treat Heart Disease The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells. Is hepatic differentiation of embryonic stem cells induced by valproic acid and cytokines? Embryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate into almost all types of cells including hepatocytes, have raised the hope of cellular replacement therapy for liver failure. Paradoxical protein might prevent cancer One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer. The study is presented in the prestigious journal Cell. U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning. The use of stem cells in regenerative medicine may also be detrimental for health The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the University of Granada and University of León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis. Penn Study Provides First Clear Idea of How Rare Bone Disease Progresses An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton. Iowa State University researcher discovers key to vital DNA, protein interaction A researcher at Iowa State University has discovered how a group of proteins from plant pathogenic bacteria interact with DNA in the plant cell, opening up the possibility for what the scientist calls a "cascade of advances." Scientists successfully reprogram blood cells Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome. More Stem Cells Current Events and Stem Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||